About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Esr1tm1Ksk
targeted mutation 1, Kenneth S Korach
MGI:2150897
Summary 17 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Esr1tm1Ksk/Esr1tm1Ksk B6.129P2-Esr1tm1Ksk MGI:4398702
hm2
Esr1tm1Ksk/Esr1tm1Ksk B6.129P2-Esr1tm1Ksk/J MGI:3839858
hm3
Esr1tm1Ksk/Esr1tm1Ksk involves: 129P2/OlaHsd MGI:3688155
hm4
Esr1tm1Ksk/Esr1tm1Ksk involves: 129P2/OlaHsd * 129S6/SvEvTac MGI:4418904
hm5
Esr1tm1Ksk/Esr1tm1Ksk involves: 129P2/OlaHsd * C57BL/6 MGI:4398705
hm6
Esr1tm1Ksk/Esr1tm1Ksk involves: 129P2/OlaHsd * C57BL/6J MGI:2664581
hm7
Esr1tm1Ksk/Esr1tm1Ksk involves: 129P2/OlaHsd * C57BL/6N MGI:4398704
hm8
Esr1tm1Ksk/Esr1tm1Ksk involves: 129P2/OlaHsd * C57BL/6 * SJL MGI:4437741
ht9
Esr1tm1Ksk/Esr1+ involves: 129P2/OlaHsd MGI:4398701
cx10
Apoetm1Bres/Apoetm1Bres
Esr1tm1Ksk/Esr1tm1Ksk
B6.129P2-Apoetm1Bres Esr1tm1Ksk MGI:4437892
cx11
Esr1tm1Ksk/Esr1tm1Ksk
Esr2tm1Unc/Esr2tm1Unc
involves: 129P2/OlaHsd MGI:2664687
cx12
Esr1tm1Ksk/Esr1tm1Ksk
Esr2tm1Unc/Esr2tm1Unc
Inhatm1Bay/Inha+
involves: 129P2/OlaHsd * 129S6/SvEvTac * 129S7/SvEvBrd MGI:4418903
cx13
Esr1tm1Ksk/Esr1tm1Ksk
Inhatm1Bay/Inhatm1Bay
involves: 129P2/OlaHsd * 129S6/SvEvTac * 129S7/SvEvBrd MGI:4418905
cx14
Esr1tm1Ksk/Esr1tm1Ksk
Esr2tm1Unc/Esr2tm1Unc
Inhatm1Bay/Inhatm1Bay
involves: 129P2/OlaHsd * 129S6/SvEvTac * 129S7/SvEvBrd MGI:4418901
cx15
Esr1tm1Ksk/Esr1tm1Ksk
Esr2tm1Unc/Esr2tm1Unc
involves: 129P2/OlaHsd * C57BL/6J MGI:4398703
cx16
Esr1tm1Ksk/Esr1tm1Ksk
Tg(MMTV-Erbb2)NK1Mul/0
involves: 129P2/OlaHsd * C57BL/6J * FVB/N MGI:4438040
cx17
Esr1tm1Ksk/Esr1tm1Ksk
Tg(Wnt1)1Hev/0
involves: 129P2/OlaHsd * C57BL/6 * SJL MGI:4437739


Genotype
MGI:4398702
hm1
Allelic
Composition
Esr1tm1Ksk/Esr1tm1Ksk
Genetic
Background
B6.129P2-Esr1tm1Ksk
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Esr1tm1Ksk mutation (2 available); any Esr1 mutation (68 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
adipose tissue
N
• no significant difference in the amount of brown adipose tissue is detected in male or females at any age
• progressive increase in the amount of white adipose tissue with age in males
• at 180 days of age the numbers of adipocytes in the perirenal and epididymal fat pads are significantly increased
• at 90 days of age the number of adipocytes is increased in females
• at 180 days of age the areas of adipocytes from the perirenal and epididymal fat pads are significantly increased
• at 90 days of age the size of adipocytes is increased in females
• in males at 30 and 90 days of age
• in males and females at 90 days of age
• in males at between 270 and 360 days of age
• in females at 90 days of age

homeostasis/metabolism
• in males compared to wild-type littermate controls
• glucose levels are higher at 30, 60 and 120 min after a glucose challenge in males compared to similarly treated wild-type males
• glucose tolerance is also impaired in females
• following a glucose challenge insulin levels are significantly increased in males and females compared to wild-type controls

behavior/neurological
N
• no increase in food intake is seen despite the increase in the amount of white adipose tissue
• retention is impaired in an inhibitory avoidance assay
• treatment with estradiol improves retention to a level similar to that in estradiol treated wild-type controls
• female mice exhibit an increased threshold to mechanical nociception compared with similarly treated wild-type female mice
• however, male mice exhibit normal mechanical nociception
• female mice exhibit an increased threshold to mechanical nociception following inflammation compared with similarly treated wild-type female mice
• however, male mice exhibit normal mechanical nociception after inflammation

growth/size/body
• by 11 months of age males weigh 16% more than wild-type males




Genotype
MGI:3839858
hm2
Allelic
Composition
Esr1tm1Ksk/Esr1tm1Ksk
Genetic
Background
B6.129P2-Esr1tm1Ksk/J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Esr1tm1Ksk mutation (2 available); any Esr1 mutation (68 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
reproductive system
• in some mice

endocrine/exocrine glands

cellular
• in some mice




Genotype
MGI:3688155
hm3
Allelic
Composition
Esr1tm1Ksk/Esr1tm1Ksk
Genetic
Background
involves: 129P2/OlaHsd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Esr1tm1Ksk mutation (2 available); any Esr1 mutation (68 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
reproductive system
• hemorrhagic ovarian follicles (J:55147)
• atretic hemorrhagic follicular cysts (J:64639)
• cauda epididymides show a reduced concentration of sperm
(J:55147)
• in untreated females (J:64639)
• however, females grafted with a heterozygous pituitary gland display hypertrophied luteal cells that are highly vacuolated with lipid droplets indicating steroidogenesis (J:64639)
• follicles develop to the large antral stage but fail to progress further
• antral stage follicles contain apoptotic granulosa cells and degenerating oocytes
(J:55147)
• atretic hemorrhagic follicular cysts (J:64639)
(J:72221)
• in untreated mice (J:72221)
• however, mice do not display diethylstilbestrol (DES) induced reduction in uterine weight (J:72221)
(J:152738)
• epithelium is not cornified
• descended testes are higher in the cremaster sac compared to wild-type littermates
• the cremaster sac is smaller in length and width and has a much thicker layer of cremaster muscle
• mutants exhibit glycogen-containing cells at the rete testis-efferent ductile junction (J:60490)
• at 21 to 25 weeks of age in 4 males 6 of 8 testis were retracted up to near the bladder neck (J:112350)
• however, external examination did not reveal any defect in testicular descent (J:112350)
(J:83231)
• dilated rete testis compared to wild-type (J:125658)
• degenerate, empty tubules
• transient increase in testis weight between 32 and 81 days of age and a decrease by 185 days
• after ductal occlusion testes of mutants weigh 30% more than wild-type, due to luminal fluid accumulation
• increase in the prevalence of blind-ending efferent tubules; these blind-ending tubules have an empty and collapsaed lumen, and epithelial cells contain fewer cytoplasmic organelles, particularly lysosomes and endocytotic vesicles
• the blind-ending tubules often contain enlarged bulbous endings that are never seen in wild-type
• efferent ductule epithelial height is reduced by 48%
• number of cilia per epithelial cell is reduced and the cilia do not show the typical parallel arrangement
• microvilli of nonciliated cells of efferent ductules along the apical border are often missing and when present, are 64% shorter in length
• nonciliated cells have missing or greatly reduced endocytotic apparatus
• efferent tubules are dilated between 130 to 300% over wild-type ductules (J:60490)
• efferent ductules are swollen, with luminal areas more than twice the size of wild-type males (J:83231)
(J:125658)
• increase in the prevalence of blind-ending efferent tubules
• tubular diameters of the initial segment epididymides are dilated
• apical, narrow, and clear cells of the epididymis are abnormal in some regions
• sperm granulomas are seen in the corpus and cauda regions of 1/3 of mutant males
• initial segment epithelium is displaced into regions adjacent to the rete tesis and in short segments of the common region of efferent ductule (J:60490)
• endocytotic vesicles and large PAS+ lysosomal granules are reduced or missing in the epithelium of the epididymis (J:83231)
• epididymal epithelium is decreased in height by 45% (J:83231)
• treatment with exogenous pregnant mare serum gonadotropin followed by human chorionic gonadotropin fails to induce ovulation
• transplanted wild-type embryos fail to implant in ovariectomized hormone treated females
• nodules that do form contain only decidualized uterine tissue
• after unilateral occlusion, rete testes secretes significantly less fluid in 24 hours than wild-type
• efferent ductules from mutants treated with an anti-estorgen compound are incapable of reabsorbing luminal fluid while wild-type ductules remove most of the fluid within 3 hours
• males are sterile

cellular
• cauda epididymides show a reduced concentration of sperm

nervous system
• modest decrease in lactotroph cell density
• patterns of staining for a gonadotropin subunit proteins are altered

hematopoietic system
N
• despite absence of Esr1, cultured bone marrow stromal cells respond to estrogen to depress B cell precursor expansion
• decrease in the percentage of CD45R+, sIgM+ B cells in the bone marrow
• decrease in the percentages of mature and CD45R+, sIgM+ B cells in the bone marrow
• decrease in the percentage of mature B cells in the bone marrow

homeostasis/metabolism
• in ovariectomized female mice
• 8 times higher in female mice compared with wild-type mice
• in ovariectomized female mice
• in adult females
• in ovariectomized females treated with estradiol prolactin levels remain low unlike in wild-type mice
• prior to and after tamoxifen treatment
• mice exhibit insulin resistance compared with wild-type mice
• treatment with tamoxifen increases insulin sensitivity but mice remain insulin resistant compared with wild-type mice 15 and 30 minutes after treatment
• however, tamoxifen-treatment eventually restores normal insulin sensitivity
• around 7 to 8 months, female mice exhibit increased albumin excretion compared with wild-type mice
• however, male mice and ovariectomized female mice exhibit normal albumin excretion
• thymic atrophy induced by E2 treatment is attenuated compared to in similarly treated wild type mice (J:131313)
• E2 induced accumulation of DN1 and reduction of DN2 thymocytes is completely abrogated compared to in wild-type mice (J:131313)
• following treatment with 17beta-estradiol, female mice does not exhibit an increase in uterine weight unlike similarly treated wild-type mice (J:152738)
• treatment with PPT (propyl(1H) pyrazole-1,3,5-triyl-trisphenol) protects mice from accoustic trauma unlike similarly treated wild-type mice
• do not display diethylstilbestrol (DES) induced reduction in uterine weight, increase in body weight, or pathological changes in reproductive tissues

cardiovascular system
N
• mice exhibit normal estrogen- and estrogen-dendrimer conjugate (EDC)-induced reendothelialization following arterial denudation
• hemorrhagic ovarian follicles (J:55147)
• atretic hemorrhagic follicular cysts (J:64639)

muscle
• the cremaster sac is smaller in length and width and has a much thicker layer of cremaster muscle
• cross sectional width of the cremaster muscle at its abdominal wall attachment and at its tip is about twice that of wild-type controls

immune system
• decrease in the percentage of CD45R+, sIgM+ B cells in the bone marrow
• decrease in the percentage of mature B cells in the bone marrow
• sperm granulomas are seen in the corpus and cauda regions of 1/3 of mutant males

endocrine/exocrine glands
• hemorrhagic ovarian follicles (J:55147)
• atretic hemorrhagic follicular cysts (J:64639)
• modest decrease in lactotroph cell density
• only a rudimentary ductal structure is present
• in ovariectomized females treated with estradiol mammary glands do not exhibit any growth
• restoring prolactin levels by grafting half a heterozygous pituitary gland induces dramatic mammary gland growth in ovary intact females
• hormone treatment with estradiol and progesterone stimulates ductal branching and lobuloalveolar development and terminal end bud formation
(J:55147)
• in untreated females (J:64639)
• however, females grafted with a heterozygous pituitary gland display hypertrophied luteal cells that are highly vacuolated with lipid droplets indicating steroidogenesis (J:64639)
• follicles develop to the large antral stage but fail to progress further
• antral stage follicles contain apoptotic granulosa cells and degenerating oocytes
(J:55147)
• atretic hemorrhagic follicular cysts (J:64639)
(J:72221)
• mutants exhibit glycogen-containing cells at the rete testis-efferent ductile junction (J:60490)
• at 21 to 25 weeks of age in 4 males 6 of 8 testis were retracted up to near the bladder neck (J:112350)
• however, external examination did not reveal any defect in testicular descent (J:112350)
(J:83231)
• dilated rete testis compared to wild-type (J:125658)
• degenerate, empty tubules
• transient increase in testis weight between 32 and 81 days of age and a decrease by 185 days
• after ductal occlusion testes of mutants weigh 30% more than wild-type, due to luminal fluid accumulation
• patterns of staining for a gonadotropin subunit proteins are altered

growth/size/body
(J:55147)
• atretic hemorrhagic follicular cysts (J:64639)
(J:72221)
• in untreated females (J:72221)
• however, mice do not display diethylstilbestrol (DES) induced increase in body weight (J:72221)
• in female mice (J:152738)
• at 9 and 18 months, crown to rump length is decreased compared to Esr1tm1Ksk Esr2tm1Unc homozygotes

limbs/digits/tail
• at 4, 9, and 18 months, femur length is decreased compared to in Esr1tm1Ksk Esr2tm1Unc homozygotes

skeleton
• at 4, 9, and 18 months, femur length is decreased compared to in Esr1tm1Ksk Esr2tm1Unc homozygotes
• at 18 months, vertebra height is decreased compared to in Esr1tm1Ksk Esr2tm1Unc homozygotes
• at 4 months, femur growth velocity is reduced compared to in wild-type mice
• at 18 months, the growth plates in the femur and tibia are fused unlike in wild-type mice
• column density is decreased compared to in Esr1tm1Ksk Esr2tm1Unc homozygotes
• at 4 months, the femur growth plate exhibit decreased height compared to in wild-type mice
• at 18 months, the tibia and femur growth plates exhibit decreased height compared to in wild-type mice
• chondrocyte proliferation in the femur is increased compared to in Esr1tm1Ksk Esr2tm1Unc homozygotes
• however, chondrocyte proliferation in the tibia and vertebra is normal

renal/urinary system
• around 7 to 8 months, female mice exhibit increased albumin excretion compared with wild-type mice
• however, male mice and ovariectomized female mice exhibit normal albumin excretion
• female mice exhibit diffuse mesangial matrix expansion compared with wild-type mice
• at 9 months, female mice exhibit an increase in glomerular size compared with wild-type mice
• however, ovariectomized female mice exhibit normal glomerular size

integument
• only a rudimentary ductal structure is present
• in ovariectomized females treated with estradiol mammary glands do not exhibit any growth
• restoring prolactin levels by grafting half a heterozygous pituitary gland induces dramatic mammary gland growth in ovary intact females
• hormone treatment with estradiol and progesterone stimulates ductal branching and lobuloalveolar development and terminal end bud formation




Genotype
MGI:4418904
hm4
Allelic
Composition
Esr1tm1Ksk/Esr1tm1Ksk
Genetic
Background
involves: 129P2/OlaHsd * 129S6/SvEvTac
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Esr1tm1Ksk mutation (2 available); any Esr1 mutation (68 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
reproductive system

homeostasis/metabolism

endocrine/exocrine glands




Genotype
MGI:4398705
hm5
Allelic
Composition
Esr1tm1Ksk/Esr1tm1Ksk
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Esr1tm1Ksk mutation (2 available); any Esr1 mutation (68 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cardiovascular system
• following induced ischemia hearts take longer to resume regular beating, produce more nitrite, accumulate more calcium, reduce less MTT indicting a more severe impairment of mitochondrial respiratory function, and show more extensive and intense cellular damage

homeostasis/metabolism
• following induced ischemia hearts take longer to resume regular beating, produce more nitrite, accumulate more calcium, reduce less MTT indicting a more severe impairment of mitochondrial respiratory function, and show more extensive and intense cellular damage




Genotype
MGI:2664581
hm6
Allelic
Composition
Esr1tm1Ksk/Esr1tm1Ksk
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Esr1tm1Ksk mutation (2 available); any Esr1 mutation (68 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• male mice showed a decrease in aggressive behavior relative to wild-type
• in a resident intruder assay aggressive behaviors toward the intruder male are greatly reduced
• loss of offensive attacks is also seen when males are tested in a neutral cage
• gonadally intact females exhibit higher levels of aggression toward gonadectomized and steroid-primed female intruders, however gonadectomized mutant females do not show increased aggression
• male mice exhibited female-type open field behavior including increased activity
• male mice exhibited female-type open field behavior including increased rearing
• gondadally intact and gonadectomized females showed greatly reduced levels of parental behavior toward newborn pups placed in their home cage
• noninfanticidal female mutants displayed reduced levels of retrieving behavior
• about 40% of mutant females displayed infanticidal behavior
• males housed overnight with hormone-primed wild-type females produced significantly fewer copulatory plugs than heterozygous or wild-type males
• males mounted females but made fewer intromissions
• females fail to show lordosis posture or receptiveness to wild-type males even when treated with estrogen (J:16338)
• gonadectomized females showed rejections toward male sexual behavior about 80% of the time (J:51468)
• estrogen or estrogen plus progesterone-treated gonadectomized females showed prereceptive posture but did not display lordosis behavior (J:51468)

reproductive system
• the sperm motility of 8-16-wk-old males declines from 20% to less than 1% during a 90-min period of in vitro capacitation
• mutant sperm beat less vigorously and display less forward progression than wild-type sperm
• containing few granulosa cells
• hyperemic cystic ovaries
• hemorrhagic ovarian cysts
• the lumen of the rete testis became significantly dilated at 60 days after birth
• however, the efferent ductules and epididymides showed no signs of dilation or dysmorphology in young or adult mice
• by 20-24 weeks of age, seminiferous tubules either had a dilated lumen and a thin layer of Sertoli cells or a disorganized epithelium with few spermatogonia or lacked a lumen and contained mostly Sertoli cells
• at 20 days after birth, the seminiferous epithelium is thinner than normal
• at 20 days after birth, the lumen of seminiferous tubules was significantly dilated
• tubule dilation progressed with age and became more pronounced at 60 days after birth
• degenerating seminiferous tubules were observed beginning at 10 to 12 weeks of age
• degeneration was initiated at the caudal pole of the testis and progressed in a wave to the cranial pole between 3-6 months of age
• only a few partially intact tubules were noted at the cranial pole at 6 months of age
(J:16338)
• at 20-23 weeks of age, the weight of mutant testis was significantly lower than that of wild-type or heterozygous males (J:36658)
• in contrast, the weights of the seminal glands, coagulating glands, and epididymi remained normal at 5-6 months of age (J:36658)
• the percentage area of the uterus innervated by PGP 9.5 and DBH immunoreactive nerves is increased even when normalized for the decrease in uterine size
• endometrial stroma is less dense, approaching a mesh like morphology in extreme cases
• at 118 days of age
• stromal, epithelial, and myometrial tissue compartments are all reduced
• however, all major cell types are present
• disruption of spermatogenesis evident after 10 weeks of age
• spermatogenesis occurs in the seminiferous tubules of some mutants at 3-5 months of age
• sperm count was 10% that of wild-type (J:16338)
• a reduced concentration of epididymal sperm was noted in the caput region at 10 weeks of age, and in more distal regions at 20 weeks of age (J:36658)
• sperm counts declined and became significantly lower than those of wild-type controls by 12-13 weeks of age (J:36658)
• sperm with retroflexed bending in the midpiece region were commonly observed
• however, no major sperm head abnormalities were found to occur
• sperm heads were commonly detached from the flagellum
• by 20-24 weeks of age, epididymides were often hypospermic esp. in the caput and corpus regions
• females fail to respond to estrogen treatment
• males sired no offspring during a 2-month mating period
• 3 of 15 males sired offspring
• males that did not sire offspring also did not produce vaginal plugs
• sperm from 8-16-wk-old male mutants display a significantly reduced in vitro fertilization capacity relative to wild-type sperm
• ejaculations were never observed in mutants (J:38600)
• when placed with a receptive female for 90 min, males display mounts and intromissions but fail to ejaculate (J:66582)

homeostasis/metabolism
• at 20-23 weeks of age, serum testosterone levels are moderately increased relative to wild-type and heterozygous levels
• in contrast, serum LH and FSH levels are slightly but not significantly increased
• about a 10 fold increase in 17beta estradiol levels in females
• levels are 23% lower than in wild-type controls at 118 days of age (J:114164)
• in males at 4 months of age but not at 1 or 2 months of age
• decrease in the concentration of osteocalcin, a marker of bone formation, in the serum at 110 days of age
• in males at 4 months of age the insulin x free fatty acid product is increased suggesting the mice are insulin resistant
• in males and females at 1 year of age
• 17beta-estradiol-treated castrated mice fail to exhibit a decrease in bone marrow cellularity, immunoglobulin switching, or increased production of immunoglobulins (IgA, IgG, and IgM) and exhibit a reduced decrease in the frequency of B cells unlike similarly treated wild-type mice
• 17beta-estradiol-treated castrated mice fail to exhibit a decrease in pre-B cells and newly formed B cells unlike similarly treated wild-type mice
• however, 17beta-estradiol-treated castrated mice exhibit a decrease in pro-B cell

cardiovascular system

growth/size/body
• hemorrhagic ovarian cysts
• late pubertal and young adult body weight is decreased compared to controls
• in adult mice (over 44 days of age)
• males at 4 months of age are obese

respiratory system

skeleton
N
• unlike for the appendicular skeleton, no difference in the length of the axial skeleton is detected
• ulnae are 4% shorter and straighter than in wild-type mice
• in post-pubertal mice (J:62222)
• at 118 days of age but not at 31 or 65 days of age (J:114164)
• at 118 days of age but not at 31 or 65 days of age
• bone mineral content normalized to body weight is decreased in the total body, femur and spine
• total areal bone mineral density is slightly decreased in adults
• femur bone mineral density is decreased in adults
• decrease in mid-diaphyseal bone mineral content in the femur and tibia mainly as a result of a decrease in cross-sectional area associated with a decrease in periosteal and endosteal circumference
• under non-loading condition, cortical area is 12% greater than in wild-type mice
• load-induced increase in cortical area is reduced 3-fold compared to in similarly treated wild-type mice
• under non-loading condition, periosteal perimeter is 6% greater than in wild-type mice
• after 10 minutes of mechanical stress, the number of osteoblast-like cells is decreased unlike in similarly treated wild-type mice
• however, transfection of the endogenous gene restores the increase in load-induced osteoblast cells to levels greater than in similarly treated wild-type mice
• under non-loading condition, mice exhibit reduced endosteal mineralizing surface compared with wild-type mice
• load-induced increase in periosteal mineralization is decreased 40% compared to in similarly treated wild-type mice
• load-induced endosteal mineral apposition rate is 50% lower than in similarly treated wild-type mice
• under non-loading condition, mice exhibit reduced bone formation compared with wild-type mice
• load-induced periosteal and endosteal bone formation rates are 60% lower than in similarly treated wild-type mice
• decrease in maximal load
• however, other parameters, such as maximal stress and elastic modulus, are not significantly different from controls

embryo
• at P23 the efferent ductules are enlarged and dilated in females
• in adult females well developed and enlarged ductules with occasional epididymal-like initial segments are seen

immune system
• 17beta-estradiol-treated castrated mice fail to exhibit immunoglobulin switching unlike similarly treated wild-type mice
• mice have increased double positive CD4+CD8+ thymocytes compared to in wild-type mice
• 17beta-estradiol-treated castrated mice exhibit a reduced decrease in the frequency of B cells compared with similarly treated wild-type mice
• 17beta-estradiol-treated castrated mice fail to exhibit a decrease in pre-B cells and newly formed B cells unlike similarly treated wild-type mice
• display plasmacytosis of the spleen and kidney
• lymph nodes also display an accumulation of plasma cells
• mice have fewer single positive CD4+ and CD8+ thymocytes compared to in wild-type mice
• mice have fewer single positive CD4+ and CD8+ thymocytes compared to in wild-type mice
• despite being kept in a specific pathogen free environment mice spontaneously develop germinal centers
• 17beta-estradiol-treated castrated mice fail to exhibit an increase in production of immunoglobulins (IgA, IgG, and IgM) compared with similarly treated wild-type mice
• in females
• display an accumulation of plasma cells
• display plasmacytosis of the spleen
• seen in males and females by 1 year of age

renal/urinary system
• in males and females at 1 year of age
• show some degree of mesangial sclerosis at 1 year of age
• deposits of IgG are detected in the glomeruli
• display plasmacytosis of the kidney
• seen in males and females by 1 year of age

nervous system
• in the anteroventral periventricular nucleus the number of TH positive neurons is increased in males compared to wild-type males
• the percentage area of the uterus innervated by PGP 9.5 and DBH immunoreactive nerves is increased even when normalized for the decrease in uterine size

adipose tissue
• in males at 4 months of age but not at 1 or 2 months of age
• in males at 4 months of age
• in males at 4 months of age

endocrine/exocrine glands
• containing few granulosa cells
• hyperemic cystic ovaries
• hemorrhagic ovarian cysts
• the lumen of the rete testis became significantly dilated at 60 days after birth
• however, the efferent ductules and epididymides showed no signs of dilation or dysmorphology in young or adult mice
• by 20-24 weeks of age, seminiferous tubules either had a dilated lumen and a thin layer of Sertoli cells or a disorganized epithelium with few spermatogonia or lacked a lumen and contained mostly Sertoli cells
• at 20 days after birth, the seminiferous epithelium is thinner than normal
• at 20 days after birth, the lumen of seminiferous tubules was significantly dilated
• tubule dilation progressed with age and became more pronounced at 60 days after birth
• degenerating seminiferous tubules were observed beginning at 10 to 12 weeks of age
• degeneration was initiated at the caudal pole of the testis and progressed in a wave to the cranial pole between 3-6 months of age
• only a few partially intact tubules were noted at the cranial pole at 6 months of age
(J:16338)
• at 20-23 weeks of age, the weight of mutant testis was significantly lower than that of wild-type or heterozygous males (J:36658)
• in contrast, the weights of the seminal glands, coagulating glands, and epididymi remained normal at 5-6 months of age (J:36658)

limbs/digits/tail
• ulnae are 4% shorter and straighter than in wild-type mice
• in post-pubertal mice (J:62222)
• at 118 days of age but not at 31 or 65 days of age (J:114164)
• at 118 days of age but not at 31 or 65 days of age

hematopoietic system
• 17beta-estradiol-treated castrated mice fail to exhibit immunoglobulin switching unlike similarly treated wild-type mice
• mice have increased double positive CD4+CD8+ thymocytes compared to in wild-type mice
• 17beta-estradiol-treated castrated mice fail to exhibit a decrease in bone marrow cellularity unlike similarly treated wild-type mice
• 17beta-estradiol-treated castrated mice exhibit a reduced decrease in the frequency of B cells compared with similarly treated wild-type mice
• 17beta-estradiol-treated castrated mice fail to exhibit a decrease in pre-B cells and newly formed B cells unlike similarly treated wild-type mice
• display plasmacytosis of the spleen and kidney
• lymph nodes also display an accumulation of plasma cells
• mice have fewer single positive CD4+ and CD8+ thymocytes compared to in wild-type mice
• mice have fewer single positive CD4+ and CD8+ thymocytes compared to in wild-type mice
• despite being kept in a specific pathogen free environment mice spontaneously develop germinal centers
• 17beta-estradiol-treated castrated mice fail to exhibit an increase in production of immunoglobulins (IgA, IgG, and IgM) compared with similarly treated wild-type mice
• in females

cellular
• sperm count was 10% that of wild-type (J:16338)
• a reduced concentration of epididymal sperm was noted in the caput region at 10 weeks of age, and in more distal regions at 20 weeks of age (J:36658)
• sperm counts declined and became significantly lower than those of wild-type controls by 12-13 weeks of age (J:36658)
• sperm with retroflexed bending in the midpiece region were commonly observed
• however, no major sperm head abnormalities were found to occur
• sperm heads were commonly detached from the flagellum
• the sperm motility of 8-16-wk-old males declines from 20% to less than 1% during a 90-min period of in vitro capacitation
• mutant sperm beat less vigorously and display less forward progression than wild-type sperm




Genotype
MGI:4398704
hm7
Allelic
Composition
Esr1tm1Ksk/Esr1tm1Ksk
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Esr1tm1Ksk mutation (2 available); any Esr1 mutation (68 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
• about a 50% reduction in thymus weight
• estradiol induced thymic atrophy is reduced compared to wild-type controls and the subpopulation profile is not altered unlike in wild-type controls
• following estradiol treatment hematopoietic progenitor subsets that are decreased in number in wild-type mice are not decreased in mutants
• unlike in wild-type mice, estradiol treatment does not change the numbers of immature or mature B cells
• decrease in the number of pre/pro and immature B cells

immune system
• about a 50% reduction in thymus weight
• estradiol induced thymic atrophy is reduced compared to wild-type controls and the subpopulation profile is not altered unlike in wild-type controls
• unlike in wild-type mice, estradiol treatment does not change the numbers of immature or mature B cells
• decrease in the number of pre/pro and immature B cells

endocrine/exocrine glands
• about a 50% reduction in thymus weight
• estradiol induced thymic atrophy is reduced compared to wild-type controls and the subpopulation profile is not altered unlike in wild-type controls




Genotype
MGI:4437741
hm8
Allelic
Composition
Esr1tm1Ksk/Esr1tm1Ksk
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Esr1tm1Ksk mutation (2 available); any Esr1 mutation (68 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
• underdeveloped at 10 weeks of age with a rudimentary ductal network confined to the nipple region

integument
• underdeveloped at 10 weeks of age with a rudimentary ductal network confined to the nipple region




Genotype
MGI:4398701
ht9
Allelic
Composition
Esr1tm1Ksk/Esr1+
Genetic
Background
involves: 129P2/OlaHsd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Esr1tm1Ksk mutation (2 available); any Esr1 mutation (68 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
reproductive system
• at 21 to 25 weeks of age in 4 males 5 of 8 testis were retracted up to near the bladder neck
• however, external examination did not reveal any defect in testicular descent

muscle
• the cremaster sac is smaller in length and width and has a much thicker layer of cremaster muscle
• cross sectional width of the cremaster muscle at its abdominal wall attachment and at its tip is about twice that of wild-type controls

endocrine/exocrine glands
• at 21 to 25 weeks of age in 4 males 5 of 8 testis were retracted up to near the bladder neck
• however, external examination did not reveal any defect in testicular descent




Genotype
MGI:4437892
cx10
Allelic
Composition
Apoetm1Bres/Apoetm1Bres
Esr1tm1Ksk/Esr1tm1Ksk
Genetic
Background
B6.129P2-Apoetm1Bres Esr1tm1Ksk
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Apoetm1Bres mutation (9 available); any Apoe mutation (156 available)
Esr1tm1Ksk mutation (2 available); any Esr1 mutation (68 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cardiovascular system
• in ovariectomized females the ability of treatment with estradiol to inhibit lesion progression is impaired

homeostasis/metabolism
N
• unlike ovariectomized wild-type for Esr1, xanthoma formation is rarely seen
• in ovariectomized females exogenous estradiol treatment fails to reduce fasting plasma cholesterol

reproductive system
• in ovariectomized females implanted with estradiol




Genotype
MGI:2664687
cx11
Allelic
Composition
Esr1tm1Ksk/Esr1tm1Ksk
Esr2tm1Unc/Esr2tm1Unc
Genetic
Background
involves: 129P2/OlaHsd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Esr1tm1Ksk mutation (2 available); any Esr1 mutation (68 available)
Esr2tm1Unc mutation (4 available); any Esr2 mutation (36 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
reproductive system
• 80% reduction in epididymal sperm count relative to wild-type
• 5% reduction in the motility of sperm obtained from the epididymis
• postnatal transdifferentiation of portions of the ovary, resulting in structures resembling seminiferous tubules
• these tubule-like structures contained degenerating granulosa cells, sertoli-like cells, and in some cases, degenerating oocytes
• evident at 2.5 to 7 months of age
• however, normal development of Mullerian-derived structures (uterus, cervix, and upper vagina) is seen

skeleton
• at 4, 9, and 18 months, femur length is increased compared to in Esr1tm1Ksk homozygotes
• at 18 months, vertebra height is increased compared to in to Esr1tm1Ksk homozygotes

endocrine/exocrine glands
• postnatal transdifferentiation of portions of the ovary, resulting in structures resembling seminiferous tubules
• these tubule-like structures contained degenerating granulosa cells, sertoli-like cells, and in some cases, degenerating oocytes

homeostasis/metabolism
• higher than those observed in Esr1tm1Ksk homozygous mice

growth/size/body
• at 9 and 18 months, crown to rump length is increased compared to Esr1tm1Ksk homozygotes

limbs/digits/tail
• at 4, 9, and 18 months, femur length is increased compared to in Esr1tm1Ksk homozygotes

cellular
• 80% reduction in epididymal sperm count relative to wild-type
• 5% reduction in the motility of sperm obtained from the epididymis




Genotype
MGI:4418903
cx12
Allelic
Composition
Esr1tm1Ksk/Esr1tm1Ksk
Esr2tm1Unc/Esr2tm1Unc
Inhatm1Bay/Inha+
Genetic
Background
involves: 129P2/OlaHsd * 129S6/SvEvTac * 129S7/SvEvBrd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Esr1tm1Ksk mutation (2 available); any Esr1 mutation (68 available)
Esr2tm1Unc mutation (4 available); any Esr2 mutation (36 available)
Inhatm1Bay mutation (0 available); any Inha mutation (9 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
reproductive system
• ovaries develop tubule-like structures unlike in wild-type mice

neoplasm

endocrine/exocrine glands
• ovaries develop tubule-like structures unlike in wild-type mice




Genotype
MGI:4418905
cx13
Allelic
Composition
Esr1tm1Ksk/Esr1tm1Ksk
Inhatm1Bay/Inhatm1Bay
Genetic
Background
involves: 129P2/OlaHsd * 129S6/SvEvTac * 129S7/SvEvBrd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Esr1tm1Ksk mutation (2 available); any Esr1 mutation (68 available)
Inhatm1Bay mutation (0 available); any Inha mutation (9 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• male mice exhibit reduced survival compared with Esr1tm1Ksk homozygotes that is similar to in Inhatm1Bay homozygotes
• female mice exhibit reduced survival compared with Esr1tm1Ksk or Inhatm1Bay homozygotes

neoplasm
• tumors are larger than in Inhatm1Bay homozygotes
• tumors contain tubule-like follicle-like structures
• tumor cells contain diffuse granulosa-like cells

growth/size/body
• in female mice compared with Esr1tm1Ksk homozygotes, Inhatm1Bay homozygotes, and wild-type mice
• mice develop rapid cancer-associated wasting unlike wild-type mice that is more severe than in Inhatm1Bay homozygotes

homeostasis/metabolism
• in terminal mice compared with Inhatm1Bay homozygotes
• in terminal mice compared with Inhatm1Bay homozygotes

digestive/alimentary system
• terminal mice exhibit mucosal atrophy in the stomach unlike in wild-type mice
• terminal mice exhibit depletion of parietal cells in the glandular stomach unlike in wild-type mice

immune system

liver/biliary system
• hepatocytes in terminal mice are darkened irregularly shaped and round surrounding the central vein unlike in wild-type mice
• in terminal mice

skeleton
• in terminal mice

endocrine/exocrine glands
• tumors are larger than in Inhatm1Bay homozygotes
• tumors contain tubule-like follicle-like structures
• tumor cells contain diffuse granulosa-like cells

reproductive system
• tumors are larger than in Inhatm1Bay homozygotes
• tumors contain tubule-like follicle-like structures
• tumor cells contain diffuse granulosa-like cells




Genotype
MGI:4418901
cx14
Allelic
Composition
Esr1tm1Ksk/Esr1tm1Ksk
Esr2tm1Unc/Esr2tm1Unc
Inhatm1Bay/Inhatm1Bay
Genetic
Background
involves: 129P2/OlaHsd * 129S6/SvEvTac * 129S7/SvEvBrd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Esr1tm1Ksk mutation (2 available); any Esr1 mutation (68 available)
Esr2tm1Unc mutation (4 available); any Esr2 mutation (36 available)
Inhatm1Bay mutation (0 available); any Inha mutation (9 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• most female mice die between 4 and 6 weeks of age and all die by 9 weeks of age
• male mice survival 19 weeks

reproductive system
• male germ cells are depleted and degenerated
• tubule-like structures resembling Sertoli-like cells are found adjacent to tumor unlike in wild-type mice
• mice develop aggressive bilateral ovarian tumors with hemorrhagic foci
• tumors contain granulosa-like cells
• tubule lumens are filled with Sertoli cells unlike in wild-type mice
• mice develop testicular tumors formed of granulosa-like cells with numerous sites of hemorrhage
• mice fail to develop early Sertoli cells unlike in Esr1tm1Ksk Inhatm1Bay or Esr2tm1Unc Inhatm1Bay double homozygotes

neoplasm
• mice develop aggressive bilateral ovarian tumors with hemorrhagic foci
• tumors contain granulosa-like cells
• mice develop testicular tumors formed of granulosa-like cells with numerous sites of hemorrhage
• mice fail to develop early Sertoli cells unlike in Esr1tm1Ksk Inhatm1Bay or Esr2tm1Unc Inhatm1Bay double homozygotes

growth/size/body
• compared with Esr1tm1Ksk and Esr2tm1Unc single homozygotes
• at 26 weeks
• compared to in Inhatm1Bay

homeostasis/metabolism

endocrine/exocrine glands
• tubule-like structures resembling Sertoli-like cells are found adjacent to tumor unlike in wild-type mice
• mice develop aggressive bilateral ovarian tumors with hemorrhagic foci
• tumors contain granulosa-like cells
• tubule lumens are filled with Sertoli cells unlike in wild-type mice
• mice develop testicular tumors formed of granulosa-like cells with numerous sites of hemorrhage
• mice fail to develop early Sertoli cells unlike in Esr1tm1Ksk Inhatm1Bay or Esr2tm1Unc Inhatm1Bay double homozygotes

cellular
• male germ cells are depleted and degenerated




Genotype
MGI:4398703
cx15
Allelic
Composition
Esr1tm1Ksk/Esr1tm1Ksk
Esr2tm1Unc/Esr2tm1Unc
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Esr1tm1Ksk mutation (2 available); any Esr1 mutation (68 available)
Esr2tm1Unc mutation (4 available); any Esr2 mutation (36 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
reproductive system
• 17beta-estradiol-induced increase in uterus weight is less than in similarly treated wild-type mice
• during a 30 min interaction with a receptive female males failed to show any ejaculations

behavior/neurological
• in a resident intruder assay aggressive behaviors toward the intruder male are greatly reduced and mice rarely show offensive attacks
• loss of offensive attacks is also seen when males are tested in a neutral cage
• about 50% of males display defensive type aggression towards receptive females
• during a 30 min interaction with a receptive female males failed to show any ultrasonic vocalizations, mounts, or intromissions; similar results are seen when the interaction is extended to 90 min

skeleton
• in post-pubertal mice
• bone mineral content normalized to body weight is decreased in the total body, femur and spine
• total areal bone mineral density is slightly decreased in adults
• femur bone mineral density is decreased in adults
• decrease in mid-diaphyseal bone mineral content in the femur and tibia mainly as a result of a decrease in cross-sectional area associated with a decrease in periosteal and endosteal circumference

homeostasis/metabolism
• in males at 4 months of age but not at 1 or 2 months of age
• decrease in the concentration of osteocalcin, a marker of bone formation, in the serum at 110 days of age
• in males at 4 months of age the insulin x free fatty acid product is increased suggesting the mice are insulin resistant
• 17beta-estradiol-induced increase in uterus weight is less than in similarly treated wild-type mice (J:115411)
• treatment with 17beta-estradiol fails to inhibit vascular injury-induced increases in medial area unlike in similarly treated wild-type mice (J:115411)
• however, vascular smooth muscle cell proliferation following injury and 17beta-estradiol treatment is normal (J:115411)
• 17beta-estradiol-treated castrated mice fail to exhibit a decrease in bone marrow cellularity, a reduced decrease in the frequency of B cells, immunoglobulin switching, or an increase in production of immunoglobulins (IgA, IgG, and IgM) unlike similarly treated wild-type mice (J:82423)

growth/size/body
• late pubertal and young adult body weight is decreased compared to controls
• males at 4 months of age are obese

limbs/digits/tail
• in post-pubertal mice

immune system
• 17beta-estradiol-treated castrated mice fail to exhibit immunoglobulin switching unlike similarly treated wild-type mice
• mice have increased double positive CD4+CD8+ thymocytes compared to in wild-type mice
• 17beta-estradiol-treated castrated mice fail to exhibit a reduced decrease in the frequency of B cells (including pre-B cells, pro-B cells, and newly formed B cells) compared with similarly treated wild-type mice
• mice have fewer single positive CD4+ and CD8+ thymocytes compared to in wild-type mice
• mice have fewer single positive CD4+ and CD8+ thymocytes compared to in wild-type mice
• 17beta-estradiol-treated castrated mice fail to exhibit an increase in production of immunoglobulins (IgA, IgG, and IgM) compared with similarly treated wild-type mice

adipose tissue
• in males at 4 months of age but not at 1 or 2 months of age
• in males at 4 months of age
• in males at 4 months of age

hematopoietic system
• 17beta-estradiol-treated castrated mice fail to exhibit immunoglobulin switching unlike similarly treated wild-type mice
• mice have increased double positive CD4+CD8+ thymocytes compared to in wild-type mice
• 17beta-estradiol-treated castrated mice fail to exhibit a decrease in bone marrow cellularity unlike similarly treated wild-type mice
• 17beta-estradiol-treated castrated mice fail to exhibit a reduced decrease in the frequency of B cells (including pre-B cells, pro-B cells, and newly formed B cells) compared with similarly treated wild-type mice
• mice have fewer single positive CD4+ and CD8+ thymocytes compared to in wild-type mice
• mice have fewer single positive CD4+ and CD8+ thymocytes compared to in wild-type mice
• 17beta-estradiol-treated castrated mice fail to exhibit an increase in production of immunoglobulins (IgA, IgG, and IgM) compared with similarly treated wild-type mice

endocrine/exocrine glands




Genotype
MGI:4438040
cx16
Allelic
Composition
Esr1tm1Ksk/Esr1tm1Ksk
Tg(MMTV-Erbb2)NK1Mul/0
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6J * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Esr1tm1Ksk mutation (2 available); any Esr1 mutation (68 available)
Tg(MMTV-Erbb2)NK1Mul mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• mice display 50% tumor incidence at 105 weeks of age compared to 52 weeks of age in transgenic mice wild-type for Esr1
• increasing progesterone levels accelerates tumor development

endocrine/exocrine glands
• rudimentary mammary gland that fails to develop beyond the prepubertal stage
• however, duct structure is not different from homozygous null mice not carrying the transgene

integument
• rudimentary mammary gland that fails to develop beyond the prepubertal stage
• however, duct structure is not different from homozygous null mice not carrying the transgene




Genotype
MGI:4437739
cx17
Allelic
Composition
Esr1tm1Ksk/Esr1tm1Ksk
Tg(Wnt1)1Hev/0
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Esr1tm1Ksk mutation (2 available); any Esr1 mutation (68 available)
Tg(Wnt1)1Hev mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• both sexes develop lobuloalveolar adenocarcinomas
• compared to transgenic mice wild-type for Esr1

endocrine/exocrine glands
• virgin females display underdeveloped glands at 10 weeks of age with a hyperplastic rudimentary ductal network that lacks terminal end buds
• in the interior of the gland in virgin females
• in virgin females, regions of lobuloalveolar hyperplasia at the periphery of the gland
• both sexes develop lobuloalveolar adenocarcinomas
• virgin females display underdeveloped glands at 10 weeks of age with a hyperplastic rudimentary ductal network that lacks terminal end buds
• unlike in transgenic mice wild-type for Esr1, hyperplasia does not progress with age in virgin females
• males display epithelial hyperplasia that does not extend into the inguinal fat pad similar to what is seen in females

integument
• virgin females display underdeveloped glands at 10 weeks of age with a hyperplastic rudimentary ductal network that lacks terminal end buds
• in the interior of the gland in virgin females
• in virgin females, regions of lobuloalveolar hyperplasia at the periphery of the gland
• both sexes develop lobuloalveolar adenocarcinomas
• virgin females display underdeveloped glands at 10 weeks of age with a hyperplastic rudimentary ductal network that lacks terminal end buds
• unlike in transgenic mice wild-type for Esr1, hyperplasia does not progress with age in virgin females
• males display epithelial hyperplasia that does not extend into the inguinal fat pad similar to what is seen in females





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
10/29/2024
MGI 6.24
The Jackson Laboratory